Integra LifeSciences has identified issues with certain wound and burn products that have resulted in serious injuries, the Food and Drug Administration said.

Integra LifeSciences IART reported upbeat second-quarter earnings and lowered its FY24 guidance below estimates on Monday. Integra Lifesciences posted adjusted earnings of 63 cents per share, beating ...

Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the ...

Integra LifeSciences Holdings Corporation (NASDAQ:IART) agreed to acquire Acclarent Inc. from Ethicon Inc, a Johnson & Johnson (NYSE:JNJ) MedTech company, for $275 million in cash, and an additional ...

Integra LifeSciences Holdings Corp. is seeking to establish itself in the ear, nose and throat category with its acquisition of Acclarent Inc. The Princeton-based medical technology company announced ...

In the last three months, 8 analysts have published ratings on Integra Lifesciences (NASDAQ:IART), offering a diverse range of perspectives from bullish to bearish. The table below offers a condensed ...

PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART) (Nasdaq:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice ...

PRINCETON, N.J., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holding Company (NASDAQ: IART), a leading global medical technology company, today issued its latest Environmental, Social and ...

Integra explained that it had determined that the Boston Facility deviated from good manufacturing practices in testing for bacterial endotoxin and allowed the release of products with higher levels ...

INTEGRA Biosciences is part of the Science Based Targets initiative (SBTi), a scheme that provides independent assessment and approval of companies' carbon-reduction targets according to 3 scopes. The ...